Dimensions of Psychosis in Patients with Bipolar Mania as Measured by the Positive and Negative Syndrome Scale

Background: Psychosis is present in 50% or more of patients with bipolar mania and is commonly evaluated in clinical research by means of the Positive and Negative Syndrome Scale (PANSS). The aim of the present analysis was to investigate the psychotic dimensions of bipolar disorder and its contributing symptoms based on a factor analysis of baseline PANSS scores and to compare them with those identified in studies of patients with schizophrenia and bipolar disorder. Sampling and Methods: Baseline data were analyzed from two 3-week, double-blind, placebo-controlled studies of risperidone monotherapy for acute mania associated with bipolar I disorder (n = 535). Inclusion criteria were a DSM-IV diagnosis of bipolar I disorder with manic features, with or without psychotic features, age ≧18 years, and mean baseline Young Mania Rating Scale scores ≧20. A principal component analysis of the 30 PANSS item scores of the 535 patients with a diagnosis of a manic episode at baseline was conducted. Results: Five factors were extracted by the analysis: anxiety (13.4% of the variance), negative symptoms (12.3%), depression (10.5%), excitement (10.3%), and positive symptoms (8.7%). Similar factors, in particular the negative, excitement, and positive factors, have been identified in patients with schizophrenia. There was an absence of a cognitive factor supporting the notion that bipolar patients may present fewer cognitive symptoms. Conclusion: The results of the present analysis and those of other studies indicate similarities in psychotic symptom domains, as measured by the PANSS, in patients with bipolar mania and schizophrenia. Future analyses will address the effects of treatment on the identified factors.

[1]  E. Vieta,et al.  Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. , 2005, The British journal of psychiatry : the journal of mental science.

[2]  P. Bräunig,et al.  Long-acting risperidone in stable patients with schizoaffective disorder , 2005, Journal of psychopharmacology.

[3]  M. Tohen,et al.  An excitement subscale of the Positive and Negative Syndrome Scale , 2004, Schizophrenia Research.

[4]  J. Calabrese,et al.  Psychosis in mania: specificity of its role in severity and treatment response. , 2004, The Journal of clinical psychiatry.

[5]  P. Keck,et al.  Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. , 2004, The American journal of psychiatry.

[6]  K. Boone,et al.  Relationship between positive and negative symptoms and neuropsychological scores in frontotemporal dementia and Alzheimer's disease , 2003, Journal of the International Neuropsychological Society.

[7]  H. Möller Bipolar disorder and schizophrenia: distinct illnesses or a continuum? , 2003, The Journal of clinical psychiatry.

[8]  M. Kokai,et al.  Features of obsessive–compulsive disorder in patients primarily diagnosed with schizophrenia , 2003, Psychiatry and clinical neurosciences.

[9]  E. Daneluzzo,et al.  PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component , 2002, Schizophrenia Research.

[10]  H. Akiskal,et al.  The significance of psychotic features in manic episodes: a report from the NIMH collaborative study. , 2001, Journal of affective disorders.

[11]  J. Calabrese,et al.  Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. , 2001, Journal of affective disorders.

[12]  G. Arana,et al.  Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. , 2000, The Journal of nervous and mental disease.

[13]  S. Marder,et al.  The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. , 1997, The Journal of clinical psychiatry.

[14]  V. Peralta,et al.  Factor Structure of Symptoms in Functional Psychoses , 1997, Biological Psychiatry.

[15]  T. Crow A Darwinian Approach to the Origins of Psychosis , 1995, British Journal of Psychiatry.

[16]  J. Lindenmayer,et al.  Five factor model of schizophrenia: Replication across samples , 1993, Schizophrenia Research.

[17]  T. Crow The Continuum of Psychosis and its Implication for the Structure of the Gene , 1986, British Journal of Psychiatry.

[18]  IN Teens,et al.  MANIC-DEPRESSIVE ILLNESS , 1986, The Lancet.

[19]  J. Lindenmayer,et al.  A new five factor model of schizophrenia , 2006, Psychiatric Quarterly.

[20]  T. Ketter,et al.  Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? , 2004, Journal of psychiatric research.

[21]  Philip D. Harvey,et al.  Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. , 1997, Psychopathology.

[22]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.